LALPATHLAB.NS Profit & Loss
Dr. Lal Path Labs Ltd.
Profit & Loss Balance Sheet Cash Flow
Profit & Loss · 4 years on file
(FY2022-23 to FY2025-26)
· fetched 2026-08-23 21:45
| Line item | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|
| Revenue from Operations | ₹20.17 Bn | ₹22.27 Bn | ₹24.61 Bn | ₹27.63 Bn | RevenueFromOperations |
| Gross Revenue (incl. inter-segment) | N/A | N/A | N/A | N/A | SegmentRevenueFromOperations |
| Other Income | ₹0.42 Bn | ₹0.69 Bn | ₹0.93 Bn | ₹1.01 Bn | OtherIncome |
| Total Income | ₹20.59 Bn | ₹22.96 Bn | ₹25.55 Bn | ₹28.64 Bn | Income |
| Cost of Materials Consumed | ₹4.47 Bn | ₹4.51 Bn | ₹4.82 Bn | ₹5.35 Bn | CostOfMaterialsConsumed |
| Purchases of Stock-in-Trade | ₹0.00 Bn | ₹0.00 Bn | ₹0.00 Bn | ₹0.00 Bn | PurchasesOfStockInTrade |
| Changes in Inventories | ₹0.00 Bn | ₹0.00 Bn | ₹0.00 Bn | ₹0.00 Bn | ChangesInInventoriesOfFinishedGoodsWorkInProgressAndStockInTrade |
| Employee Benefit Expense | ₹3.77 Bn | ₹4.25 Bn | ₹4.82 Bn | ₹5.03 Bn | EmployeeBenefitExpense |
| Finance Costs | ₹0.38 Bn | ₹0.29 Bn | ₹0.22 Bn | ₹0.23 Bn | FinanceCosts |
| Depreciation and Amortisation | ₹1.50 Bn | ₹1.44 Bn | ₹1.42 Bn | ₹1.62 Bn | DepreciationDepletionAndAmortisationExpense |
| Other Expenses | ₹7.03 Bn | ₹7.41 Bn | ₹8.02 Bn | ₹9.43 Bn | OtherExpenses |
| Total Expenses | ₹17.15 Bn | ₹17.90 Bn | ₹19.30 Bn | ₹21.65 Bn | Expenses |
| Profit Before Exceptional Items and Tax | ₹3.44 Bn | ₹5.05 Bn | ₹6.25 Bn | ₹6.99 Bn | ProfitBeforeExceptionalItemsAndTax |
| Exceptional Items | ₹0.00 Bn | ₹0.00 Bn | ₹0.00 Bn | ₹-0.30 Bn | ExceptionalItemsBeforeTax |
| Profit Before Tax | ₹3.44 Bn | ₹5.05 Bn | ₹6.25 Bn | ₹6.69 Bn | ProfitBeforeTax |
| Tax Expense | ₹1.03 Bn | ₹1.43 Bn | ₹1.32 Bn | ₹1.59 Bn | TaxExpense |
| Net Profit (incl. minority interest) | ₹2.41 Bn | ₹3.62 Bn | ₹4.92 Bn | ₹5.10 Bn | ProfitLossForPeriod |
| Net Profit (to shareholders) | ₹2.39 Bn | ₹3.58 Bn | ₹4.87 Bn | ₹5.05 Bn | ProfitOrLossAttributableToOwnersOfParent |
| Basic EPS | ₹28.82 | ₹43.05 | ₹58.48 | ₹30.24 | BasicEarningsLossPerShareFromContinuingAndDiscontinuedOperations |
| Diluted EPS | ₹28.74 | ₹42.98 | ₹58.40 | ₹30.20 | DilutedEarningsLossPerShareFromContinuingAndDiscontinuedOperations |
Every figure above is the exact value of the named XBRL element from LALPATHLAB.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).